News

Ranbaxy Laboratories has received approval from the US Food and Drug Administration (FDA) to manufacture and market Glycopyrrolate Tablets USP, 1mg and 2mg. The Ranbaxy formulations is bioequivalent

The FDA is reviewing adverse event reports of liver injury in patients taking the weight loss drug orlistat, marketed as the prescription drug, Xenical and the over-the-counter medication,

Bavarian Nordic has announced that the US authorities have initiated negotiations for a new contract to develop a freeze-dried version of the IMVAMUNE smallpox vaccine. The company said

PerkinElmer has opened a second specialized Good Manufacturing Practice (GMP) services facility. The Company has claimed that it has launched this capability in response to increasing demand for

Simcere has signed a strategic partnership with Sun Yat-Sen University Cancer Center in China. Under the agreement, Simcere and Sun Yat-Sen University Cancer Center will cooperate on researching

CSL Biotherapies (CSL) has initiated the US clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Reportedly, studies will determine the safety of CSL’s candidate vaccine and its

Novartis has reported that the European Commission (EC) has approved Xolair (omalizumab) as add-on therapy for severe persistent allergic asthma in children aged 6 to 11 years. Reportedly,

RegeneRX Biopharmaceuticals has received a Notice of Allowance in Europe for its application – Inhibition or Reversal of Skin Aging by Actin-Sequestering Peptides. Reportedly, the patent covers methods,

Nutra Pharma, a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has submitted final packaging and labeling to the Food and Drug